Careplus Group Berhad Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Careplus Group BerhadDie Gewinne des Unternehmens sind mit einer durchschnittlichen jährlichen Rate von -3.1% zurückgegangen, während in der Branche Medical Equipment die Gewinne wachsen. Die Umsätze sind gewachsen mit einer durchschnittlichen Rate von 4.6% pro Jahr.

Wichtige Informationen

-3.1%

Wachstumsrate der Gewinne

-2.2%

EPS-Wachstumsrate

Medical Equipment Wachstum der Industrie	12.3%
Wachstumsrate der Einnahmen	4.6%
Eigenkapitalrendite	-54.8%
Netto-Marge	-71.8%
Letzte Ertragsaktualisierung	30 Jun 2023

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

Careplus Group Berhad (KLSE:CAREPLS) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Feb 07

Careplus Group Berhad (KLSE:CAREPLS) Shares Fly 63% But Investors Aren't Buying For Growth

Dec 18

Is Careplus Group Berhad (KLSE:CAREPLS) Using Debt Sensibly?

Nov 23

Little Excitement Around Careplus Group Berhad's (KLSE:CAREPLS) Revenues

Sep 07

Should You Be Adding Careplus Group Berhad (KLSE:CAREPLS) To Your Watchlist Today?

Apr 01

Investors Shouldn't Be Too Comfortable With Careplus Group Berhad's (KLSE:CAREPLS) Robust Earnings

Feb 26

Could The Careplus Group Berhad (KLSE:CAREPLS) Ownership Structure Tell Us Something Useful?

Feb 13

Careplus Group Berhad (KLSE:CAREPLS) Could Easily Take On More Debt

Jan 17

Our View On Careplus Group Berhad's (KLSE:CAREPLS) CEO Pay

Dec 13

Aufschlüsselung der Einnahmen und Ausgaben

Wie Careplus Group Berhad Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

KLSE:CAREPLS Einnahmen, Ausgaben und Erträge (MYR Millions)
Datum	Einnahmen	Umsatz	Allgemeine und Verwaltungskosten
30 Jun 23	205	-147	5
31 Dec 22	262	-122	9
30 Sep 22	325	-119	9
30 Jun 22	378	-81	10
31 Mar 22	541	60	14
31 Dec 21	700	221	18
30 Sep 21	721	279	19
30 Jun 21	742	314	18
31 Mar 21	612	245	17
31 Dec 20	476	122	13
30 Sep 20	455	81	11
30 Jun 20	417	33	11
31 Mar 20	385	-5	9
31 Dec 19	365	-6	9
30 Sep 19	346	-8	11
30 Jun 19	351	-2	11
31 Mar 19	345	-1	11
31 Dec 18	339	-1	11
30 Sep 18	325	-1	10
30 Jun 18	314	-3	10
31 Mar 18	314	-6	11
31 Dec 17	323	-2	11
30 Sep 17	316	1	11
30 Jun 17	295	0	11
31 Mar 17	267	3	11
31 Dec 16	229	0	10
30 Sep 16	210	0	10
30 Jun 16	203	3	10
31 Mar 16	195	4	10
31 Dec 15	190	6	10
30 Sep 15	182	5	9
30 Jun 15	169	5	8
31 Mar 15	159	4	8
31 Dec 14	152	3	7
31 Dec 13	141	1	7
31 Oct 13	134	3	7
31 Jul 13	125	3	6

Qualität der Erträge: CAREPLS ist derzeit unrentabel.

Wachsende Gewinnspanne: CAREPLS ist derzeit unrentabel.

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: CAREPLS ist unrentabel, und die Verluste haben in den letzten 5 Jahren mit einer Rate von 3.1% pro Jahr zugenommen.

Beschleunigtes Wachstum: Das Gewinnwachstum des letzten Jahres kann nicht mit dem 5-Jahres-Durchschnitt von CAREPLS verglichen werden, da das Unternehmen derzeit nicht profitabel ist.

Erträge im Vergleich zur Industrie: CAREPLS ist unrentabel, was einen Vergleich des Gewinnwachstums des letzten Jahres mit der Branche Medical Equipment (-1.5%) erschwert.

Eigenkapitalrendite

Hohe Eigenkapitalrendite: CAREPLS hat eine negative Eigenkapitalrendite (-54.79%), da es derzeit unrentabel ist.

Careplus Group Berhad Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen vergangener Leistungen

Full year 2023 earnings released: RM0.26 loss per share (vs RM0.14 loss in FY 2022)

Full year 2023 earnings released: RM0.26 loss per share (vs RM0.14 loss in FY 2022)

Full year 2022 earnings released

Third quarter 2022 earnings released: RM0.053 loss per share (vs RM0.015 profit in 3Q 2021)

Second quarter 2022 earnings released: RM0.062 loss per share (vs RM0.20 profit in 2Q 2021)

First quarter 2022 earnings released: RM0.066 loss per share (vs RM0.23 profit in 1Q 2021)

Recent updates

Careplus Group Berhad announced that it expects to receive MYR 17.47356 million in funding

New minor risk - Financial data availability

Careplus Group Berhad (KLSE:CAREPLS) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Careplus Group Berhad (KLSE:CAREPLS) Shares Fly 63% But Investors Aren't Buying For Growth

Is Careplus Group Berhad (KLSE:CAREPLS) Using Debt Sensibly?

Careplus Group Berhad, Annual General Meeting, Oct 25, 2023

Full year 2023 earnings released: RM0.26 loss per share (vs RM0.14 loss in FY 2022)

New minor risk - Shareholder dilution

Little Excitement Around Careplus Group Berhad's (KLSE:CAREPLS) Revenues

Full year 2023 earnings released: RM0.26 loss per share (vs RM0.14 loss in FY 2022)

New major risk - Revenue and earnings growth

Careplus Group Berhad Announces the Re-Designation of Puan Hazrena Binti Yahaya as Non-Independent Director from Independent Director

Careplus Group Berhad Announces Resignation of Madam Yew Yee Peng as Executive Director

Careplus Group Berhad Appoints Loo Hui Yan as Joint Secretary

Full year 2022 earnings released

Ansell Services (Asia) Sdn. Bhd. agreed to acquire 50% stake in CAREPLUS (M) SDN. BHD from Careplus Group Berhad (KLSE:CAREPLS) for MYR 37.5 million.

Careplus Group Berhad announced that it expects to receive MYR 49.8 million in funding

Careplus Group Berhad Announces Redesignation of Yee Chow Boi from Member of Remuneration Committee to Independent and Non Executive Chairman of Remuneration Committee

Now 21% undervalued

Third quarter 2022 earnings released: RM0.053 loss per share (vs RM0.015 profit in 3Q 2021)

Insufficient new directors

Careplus Group Berhad Announces Material Litigation Update

Second quarter 2022 earnings released: RM0.062 loss per share (vs RM0.20 profit in 2Q 2021)

First quarter 2022 earnings released: RM0.066 loss per share (vs RM0.23 profit in 1Q 2021)

Careplus Group Berhad, Annual General Meeting, Jun 08, 2022

Insufficient new directors

Should You Be Adding Careplus Group Berhad (KLSE:CAREPLS) To Your Watchlist Today?

Careplus Group Berhad (KLSE:CAREPLS) Seems To Use Debt Rather Sparingly

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Insufficient new directors

Is Careplus Group Berhad (KLSE:CAREPLS) A Risky Investment?

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Is Now The Time To Put Careplus Group Berhad (KLSE:CAREPLS) On Your Watchlist?

Insufficient new directors

Investor sentiment deteriorated over the past week

Upcoming dividend of RM0.02 per share

Second quarter 2021 earnings released: EPS RM0.20 (vs RM0.067 in 2Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of RM0.02 per share

Does Careplus Group Berhad (KLSE:CAREPLS) Have A Healthy Balance Sheet?

Investor sentiment deteriorated over the past week

Careplus Group Berhad Declares Interim Dividend for the Financial Year Ending 31 December 2021, Payable on 16 June 2021

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS RM0.23 (vs RM0.011 loss in FY 2019)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investors Shouldn't Be Too Comfortable With Careplus Group Berhad's (KLSE:CAREPLS) Robust Earnings

Full year 2020 earnings released

New 90-day low: RM1.94

Could The Careplus Group Berhad (KLSE:CAREPLS) Ownership Structure Tell Us Something Useful?

Investor sentiment deteriorated over the past week

Careplus Group Berhad (KLSE:CAREPLS) Could Easily Take On More Debt

Investor sentiment improved over the past week

New 90-day low: RM2.07

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

New 90-day low: RM2.34

Our View On Careplus Group Berhad's (KLSE:CAREPLS) CEO Pay

Careplus Group Berhad (KLSE:CAREPLS) and Tang Kin San completed the acquisition of Centro Heights Sdn. Bhd. from Chang Keng Chiang, Chang Sze Wei and Chang Kai Ping.

Market pulls back on stock over the past week

Market pulls back on stock over the past week

Market bids up stock over the past week

Market bids up stock over the past week

Ansell Limited (ASX:ANN) completed the acquisition 50% stake in CAREPLUS (M) SDN. BHD from Careplus Group Berhad (KLSE:CAREPLS).

Careplus Group Berhad (KLSE:CAREPLS) and Tang Kin San signed a conditional share purchase agreement to acquire Centro Heights Sdn. Bhd. from Chang Keng Chiang, Chang Sze Wei and Chang Kai Ping for RM 3.8 million.